Experts Value CardioSecur’s Diagnostic Performance

Prof. Dr. med. Thomas Wendt

After receiving his doctorate in 1981 from J.W. Goethe Universität in Frankfurt am Main, Professor Dr. Wendt worked until 1990 as a Scientific Assistant at the Universitäts-Klinikum (University Clinic) in Frankfurt.

After his licensure in Internal Medicine (1990), and his specializations in Cardiology (1990), Sports Medicine (1992) and Physical Therapy (1994), he received his licensure as a specialist in Physical and Rehabilitative Medicine (1995).

After his time as an Attending Physician at the J.W Goethe-Universitäts Klinik, he was appointed in 1996 as the Medical Director of two rehabilitation clinics for Cardiovascular and Oncologic Diseases in Bad Nauheim.

He was then awarded the academic designation of Honorary Professor (Außerplanmäßiger Professor) in 1999, and received additional qualifications in Medical Quality Management (2006), Social Medicine (2007) and Cardiovascular Preventive Medicine Physician from the DGPR (2009).

Dr. Wendt has been working as a Cardiologist at the Kardiocentrum (Cardiac Center) in Frankfurt since 2010. He has also been a member of the Scientific Advisory Board of the German Heart Foundation for the Information and Prevention of Cardiovascular Diseases since 1993. He has been engaged as Anti-Doping Commissioner for the Hessisch Tennis Club since 2011.

Dr. Glenn van Langenhove

Dr. Glenn van Langenhove is an interventional cardiologist who graduated with distinction in 1991 from the Belgium State University in Gent. In 1999 he became an interventional cardiologist and was awarded a PhD in Electromechanical Studies at the Erasmus University, Rotterdam.

During his academic career Dr. Van Langenhove conducted extensive research in the field of Electromechanical mapping of the left ventricle, the evolution of vein graft disease after bypass surgery and research in the field of the vulnerable plaque.

For us Dr. Glenn van Langenhove answered important questions on cardiovascular diseases, prevention as well as impact of clinical studies on medical development in the cardiovascular sector.